ABT Financial Facts
Cost of products sold: 2.29BNet Sales: 5.3B
See Full Income Statement
Work in process: 326M
Noncontrolling Interests in Subsidiaries: 120M
See Full Balance Sheet
Abbott Labs (ABT) Earnings
|
Expand Research on ABT
| Next EPS Date | 7/18/24 *Est. | EPS Growth Rate | -4.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +2.1% | Revenue Growth Rate | +2.2% *Last Qtr. |
| Average % Move 1-Wk after EPS | +1.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/20  |
 |
Q420 | N/A | $0.89 | N/A | N/A | $8.48B |  |
N/A | N/A | |
| 8/17/17 | |
Q417 | $0.05 | N/A | N/A | $6.17B | $6.71B | = |  | | Details |
| 4/20/16 |
|
Q116 | $0.41 | $0.39 | +$0.02 | $4.9B | $4.78B | |
| | Details |
| 4/16/14 |
|
Q114 | $0.41 | $0.36 | +$0.05 | $5.24B | $5.29B | |
| | Details |
| 4/17/13 |
|
Q113 | $0.42 | $0.41 | +$0.01 | $5.38B | $5.42B | = | | | Details |
| 7/17/13 |
|
Q213 | $0.46 | $0.44 | +$0.02 | $5.45B | $5.53B | = | | | Details |
| 4/22/15 |
|
Q115 | $0.47 | $0.42 | +$0.05 | $4.9B | $4.85B | = | | | Details |
| 4/19/17 | |
Q117 | $0.48 | $0.43 | +$0.05 | $6.34B | $6.16B | = | | | Details |
